Companies
- Companies
- Company details
Algonomics
Summary
AlgoNomics was founded in June 1999. AlgoNomics aims to become a leading provider of structural bioinformatics tools, data mining methods and specialized databases for the treatment of human infectious diseases and cancer. In order to realize its goals AlgoNomics intends to use its technology platform to identify and improve potential therapeutic products, offer AlgoNomics' services and contract rights to other companies for the use of its drug discovery technology against payments and future royalties and to bring products from research to early stage human clinical trials. Collaborations with other biopharmaceutical firms and academic organisations are a central component of the company's business strategy.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2011 - 31 pages - $250
Mar 2011 - 49 pages - $500
Mar 2011 - 35 pages - $250
Mar 2011 - 79 pages - $500
Mar 2011 - 156 pages - $250
Sep 2011 - 106 pages - $500
Mar 2009 - 224 pages - $3,400
Mar 2011 - 249 pages - $250
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Drug discovery
- Therapeutic target
- Infectious diseases
- Oncology
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us